Lexicon Pharmaceuticals, Inc.

Direct answer

Lexicon Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker LXRX.

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the end-to-end process of identifying, advancing, and bringing to market novel therapeutic compounds. Its development pipeline includes orally administered small molecule drug candidates such as Sotagliflozin, which has successfully concluded Phase III clinical studies for treating both heart failure and type 1 diabetes, and LX9211, currently...

Can you invest in Lexicon Pharmaceuticals, Inc.?

Yes. Lexicon Pharmaceuticals, Inc. trades publicly on NASDAQ as LXRX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Lexicon Pharmaceuticals, Inc.

Detailed equity research is provided by MarketSnap.